Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 229 (6%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3283 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (13%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VARENICLINE 0.5MG TABLET Resolved 2023-05-26 2023-06-02 193227
APO-VARENICLINE 1MG TABLET Resolved 2023-11-06 2023-12-01 209366
APO-VARENICLINE 1MG TABLET Resolved 2024-04-19 2024-07-05 225764
APO-VARENICLINE 0.5MG TABLET Resolved 2024-05-31 2024-07-05 229427
APO-VARENICLINE 0.5MG TABLET Resolved 2024-08-01 2024-08-23 234277
APO-VARENICLINE 1MG TABLET Resolved 2024-08-09 2024-08-23 234996
APO-VARENICLINE 1MG TABLET Resolved 2024-09-12 2024-11-15 237348
APO-VARENICLINE 1MG TABLET Resolved 2025-01-09 2025-04-04 247385
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2017-07-25 2018-03-08 16886
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-09-27 2018-03-08 23658
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-03-08 69458
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-12-12 2019-12-23 69460
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-18 2019-05-21 82022
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-06-24 86364
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2020-07-10 89554

Showing 3341 to 3360 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DILTIAZ TZ 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1078
APO-DIPYRIDAMOLE 25MG TABLET Discontinued 2019-12-20 2020-07-30 101888
APO-DIPYRIDAMOLE 50MG TABLET Discontinued 2019-12-20 2020-07-30 101891
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2018-09-07 2018-09-15 60438
APO-DOCUSATE SODIUM 100MG CAPSULE Discontinued 2018-02-23 2019-03-29 40733
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60443
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60447
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2018-10-12 60450
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459
APO-DOXY TABS 100MG 100MG TABLET Discontinued 2017-03-30 2018-02-05 4707
APO-ENALAPRIL 10MG TABLET Discontinued 2018-09-07 2018-12-05 60462
APO-ENALAPRIL 20MG TABLET Discontinued 2018-09-07 2018-11-19 60465
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO-ESCITALOPRAM 20MG TABLET Discontinued 2018-09-07 2018-09-15 60471
APO-ESCITALOPRAM 10MG TABLET Discontinued 2018-09-07 2018-11-16 60474
APO-EXEMESTANE Discontinued 2019-06-12 2019-06-12 86552
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480

Showing 141 to 160 of 366